Schutten, J.C.; Gomes-Neto, A.W.; Navis, G.; Gansevoort, R.T.; Dullaart, R.P.F.; Kootstra-Ros, J.E.; Danel, R.M.; Goorman, F.; Gans, R.O.B.; de Borst, M.H.;
et al. Lower Plasma Magnesium, Measured by Nuclear Magnetic Resonance Spectroscopy, is Associated with Increased Risk of Developing Type 2 Diabetes Mellitus in Women: Results from a Dutch Prospective Cohort Study. J. Clin. Med. 2019, 8, 169.
https://doi.org/10.3390/jcm8020169
AMA Style
Schutten JC, Gomes-Neto AW, Navis G, Gansevoort RT, Dullaart RPF, Kootstra-Ros JE, Danel RM, Goorman F, Gans ROB, de Borst MH,
et al. Lower Plasma Magnesium, Measured by Nuclear Magnetic Resonance Spectroscopy, is Associated with Increased Risk of Developing Type 2 Diabetes Mellitus in Women: Results from a Dutch Prospective Cohort Study. Journal of Clinical Medicine. 2019; 8(2):169.
https://doi.org/10.3390/jcm8020169
Chicago/Turabian Style
Schutten, Joëlle C., António W. Gomes-Neto, Gerjan Navis, Ron T. Gansevoort, Robin P. F. Dullaart, Jenny E. Kootstra-Ros, Richard M. Danel, Frans Goorman, Rijk O. B. Gans, Martin H. de Borst,
and et al. 2019. "Lower Plasma Magnesium, Measured by Nuclear Magnetic Resonance Spectroscopy, is Associated with Increased Risk of Developing Type 2 Diabetes Mellitus in Women: Results from a Dutch Prospective Cohort Study" Journal of Clinical Medicine 8, no. 2: 169.
https://doi.org/10.3390/jcm8020169
APA Style
Schutten, J. C., Gomes-Neto, A. W., Navis, G., Gansevoort, R. T., Dullaart, R. P. F., Kootstra-Ros, J. E., Danel, R. M., Goorman, F., Gans, R. O. B., de Borst, M. H., Jeyarajah, E. J., Shalaurova, I., Otvos, J. D., Connelly, M. A., & Bakker, S. J. L.
(2019). Lower Plasma Magnesium, Measured by Nuclear Magnetic Resonance Spectroscopy, is Associated with Increased Risk of Developing Type 2 Diabetes Mellitus in Women: Results from a Dutch Prospective Cohort Study. Journal of Clinical Medicine, 8(2), 169.
https://doi.org/10.3390/jcm8020169